… There’s still time to have your voice heard by completing an online U.S. Food … the meeting, it was difficult for me to tell how our presentations were going and whether they would have an …

… Study Rationale: There is an urgent need to identify effective, safe and inexpensive drugs for … interest on ways to repurpose existing medications. A few previous epidemiologic studies showed a decreased risk of … to implement a pharmacoepidemiological study using two complementary approaches: (i) agnostic approach: in a study …

… in the gene encoding the enzyme GBA1 are among the most common genetic risk factors for Parkinson’s disease (PD). These mutations … of the nanobodies to GBA1, producing an additional tool for preserving GBA1 function. Impact on Diagnosis/Treatment of … Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies …

… Photo courtesy of AARP The Magazine Just in time for … of the disease and feeling empowered by the PD community. In his interview filled with personal anecdotes, Michael also brings …

… The Michael J. Fox Foundation (MJFF) has stepped up efforts to connect locally with the Parkinson’s community, and with support groups in particular. “It’s an … or caregiver support group is interested in hosting a presentation by a Foundation representative, please contact …

… “The goal of the Fox Foundation is to close — I really look forward to that day when I get to … given a PD diagnosis, how to manage the disease, and the latest promise in research. More than 200 years have passed … population of the people involved in research. Genetics becomes a starting point for this research and can expand to …